LG Chem Posts Wider Loss In Q4

LG Chem reported a wider fourth-quarter net loss of 1.57 trillion won versus a 899 billion won loss a year earlier, while operating loss widened to 413 billion won from 261 billion won. EBITDA ticked up to 1.10 trillion won from 1.02 trillion won, but sales fell to 11.20 trillion won from 12.28 trillion won; the results are presented pending audit review. Shares traded around 343,000 won, down about 3.11%, reflecting increased losses and revenue decline despite modest EBITDA improvement.

Analysis

Market structure: LG Chem's Q4 shows a revenue decline of ~8.8% (12.28T -> 11.20T KRW) while EBITDA ticked up ~7.8% (1.02T -> 1.10T KRW) but net loss widened ~75% (899B -> 1.57T KRW), implying operating/extraordinary charges rather than pure EBITDA-driven deterioration. Immediate winners are specialty-chemical and higher-margin peers (relative share gain if LG reduces CAPEX or exits lines); losers include commodity chemical suppliers and any leveraged counterparties to LG Chem.

Risk assessment: Tail risks include an audit-triggered impairment or valuation charge >300B KRW, a regulatory recall in materials businesses, or a sharp commodity/FX shock (KRW depreciation >5% in 30 days increases local financing stress). Timeline: expect volatile days post-audit (0–30 days), credit spread widening over weeks (30–90 days), and recovery only if margins recover in 2–4 quarters; hidden dependency: intercompany exposures with EV/battery entities and USD-linked feedstock costs.

Trade implications: Direct short LG Chem (051910.KS) position sized 2–3% NAV via stock or buy 3-month 10% OTM put spreads (risk limited) targeting 20–30% downside to ~270k–275k KRW; pair trade long Lotte Chemical (011170.KS) equal notional vs short LG Chem to capture relative margin recovery. Reduce Korea chemicals ETF exposure by ~50% within 2 weeks and reallocate to defensive industrials (e.g., utilities/food staples) until audited results.

Contrarian angles: The market may be over-discounting permanent damage—EBITDA rose, so non-cash charges could be one-offs; consider a long 6–9 month call spread on 051910.KS financed by selling nearer-term calls if audit shows <150B KRW extra charges. Exit/flip criteria: close shorts if audited adjustments <100B KRW or stock rallies >15% on credible organic guidance.

Key Decisions for Investors

• Establish a 2–3% NAV short position in LG Chem (051910.KS) using stock or buy 3-month 10% OTM put spreads; set stop-loss at +10% and a profit target of 20–30% downside (~270k–275k KRW) within 3 months.
• Enter a relative value pair: long Lotte Chemical (011170.KS) equal notional to the LG Chem short (2% NAV each) to play potential share rotation into cleaner petrochemical balance sheets over 3–6 months.
• Buy a 3–6 month put spread on LG Chem if audit results are delayed >14 days; if audit returns show charges <150B KRW, instead switch to a bullish 6–9 month call spread (buy longer-dated calls, sell nearer calls) to play mean reversion.
• Reduce overall Korea chemicals/industrial cyclicals ETF exposure by ~50% within 10 trading days and reallocate proceeds to defensive sectors (utilities, consumer staples) until audited Q4 disclosures and Korean PMI data over next 60 days clarify demand trajectory.
• Monitor these specific triggers in the next 30–60 days before adjusting positions: (a) audited adjustment size (thresholds: <100B good, 100–300B mixed, >300B negative), (b) KRW move >3% vs USD, (c) 3-month forward crude change >±10% which would materially change feedstock cost assumptions.